The transition metal-catalyzed allylic substitution reaction is a particularly versatile method for the construction of carbon-carbon and carbon-heteroatom bonds. In this regard, the rhodium-catalyzed variant has emerged as a powerful method for the regioselective and stereospecific allylic substitution of chiral nonracemic secondary and tertiary allylic carbonates with a variety of carbon- and heteroatom-based nucleophiles. In addition, recent developments have made the analogous enantioselective process possible using prochiral nucleophiles with achiral allylic electrophiles, which represents a significant advance in this area. In this Perspective, the discovery, development and applications of these conceptually orthogonal strategies to target-directed synthesis are discussed, with a particular emphasis given to those methods developed in our laboratory.
A direct and highly enantioselective rhodium-catalyzed allylic alkylation of allyl benzoate with α-substituted benzyl nitrile pronucleophiles is described. This simple protocol provides a new approach toward the synthesis of acyclic quaternary carbon stereogenic centers and provides the first example of the direct asymmetric alkylation of a nitrile anion. The synthetic utility of the nitrile products is amply demonstrated through conversion to various functional groups and the synthesis of a bioactive aryl piperazine in an expeditious four-step sequence.
As
practitioners of organic chemistry strive to deliver efficient
syntheses of the most complex natural products and drug candidates,
further innovations in synthetic strategies are required to facilitate
their efficient construction. These aspirational breakthroughs often
go hand-in-hand with considerable reductions in cost and environmental
impact. Enzyme-catalyzed reactions have become an impressive and necessary
tool that offers benefits such as increased selectivity and waste
limitation. These benefits are amplified when enzymatic processes
are conducted in a cascade in combination with novel bond-forming
strategies. In this article, we report a highly diastereoselective
synthesis of MK-1454, a potent agonist of the stimulator of interferon
gene (STING) signaling pathway. The synthesis begins with the asymmetric
construction of two fluoride-bearing deoxynucleotides. The routes
were designed for maximum convergency and selectivity, relying on
the same benign electrophilic fluorinating reagent. From these complex
subunits, four enzymes are used to construct the two bridging thiophosphates
in a highly selective, high yielding cascade process. Critical to
the success of this reaction was a thorough understanding of the role
transition metals play in bond formation.
The development of a protecting group-free, 2-step synthesis of 5-amino-2-hydroxymethyltetrahydropyran 1a from biorenewable Cyrene™ is described which renders access to BTK-inhibitor nemtabrutinib (2) more efficient and sustainable.
A highly regio- and stereospecific rhodium-catalyzed allylic alkylation of tertiary allylic carbonates with alkenyl cyanohydrin pronucleophiles is described. This protocol offers a fundamentally novel approach toward the synthesis of acyclic quaternary-substituted α,β-unsaturated ketones and thereby provides a new cross-coupling strategy for target directed synthesis. A particularly attractive feature with this process is the ability to directly couple di-, tri- and tetrasubstituted alkenyl cyanohydrin pronucleophiles to prepare the corresponding α,β-unsaturated ketone derivatives in a highly selective manner. Additionally, the chemoselective 1,4-reduction of the enone products provides rapid access to acyclic enantiomerically enriched α,α'-dialkyl-substituted ketones, which are challenging motifs to prepare using conventional enolate alkylation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.